Maternal obesity depresses essential fatty acid transport in the placenta

孕妇肥胖会抑制胎盘中必需脂肪酸的转运

基本信息

项目摘要

DESCRIPTION (provided by applicant): The candidate's five-year career goal is to become an independent investigator in the areas of maternal nutrition and placental nutrient transport and metabolism. Her long-term career objective is to build a strong translational research program, utilizing appropriate animal models and human investigations to study the effect of maternal pre-pregnancy nutrition on placental growth and function, neonatal health, and the offspring's risk of future cardiovascular disease. It is becoming increasingly clear that the placenta plays a key role in the origin of adverse fetal outcomes resulting from maternal over- or under-nutrition. In keeping with this view, the placenta is an important element in the origins of adult chronic disease. The candidate has a strong scientific background in molecular biology, immunohistochemistry, primary cell culture and small and large animal surgery. She has gained expertise in fetal physiology (especially of the cardiovascular system) and is well-versed in the literature surrounding the developmental origins of health and cardiovascular disease. Additional training is required however before she can achieve her career goal of becoming an independent investigator in maternal-fetal health. The proposed training program has been designed to provide: 1) training in placental physiology and research methodologies, 2) experience in nutritional science and research methodologies and 3) in-depth training in human investigation. The Oregon Health and Science University is an ideal environment for this training. It offers its strong reputation as a leading biomedical research and training institution; the Heart Research Center is internationally recognized for its work in fetal physiology and the developmental origins of health and disease; the Oregon National Primate Research Center is internationally recognized for its translational research in pregnancy and the Oregon Clinical and Translational Research Institute is dedicated to the development of successful trainees and young investigators in translational and clinical research. One in five women who deliver in the United States is obese (body mass index (BMI) of >30 kg/m2). This condition is associated with both short- and long-term adverse consequences for mother and her baby. Such babies are at risk for developing chronic diseases including adult-onset coronary heart disease and the metabolic syndrome. Our preliminary data show that male offspring of overweight and obese mothers have lower levels of docosaehexanoic acid - a long chain polyunsaturated (LC-PUFA) derivative of essential fatty acids - than female offspring, while no differences in LC-PUFAlevels exist between male and female offspring of lean women. Such deficiencies lead to neurological and vascular pathologies in the newborn. All of the essential LC-PUFA that are acquired by the fetus are actively transported across the placental barrier. The effect of maternal obesity on placental delivery of LC-PUFA to the fetus is unknown. Due to their rapid growth in utero, boys invest less in placental growth than girls and are at a greater risk of undernourishment and poor outcomes in response to stressful conditions. Maternal obesity exposes the placental-fetal unit to pro-inflammatory molecules. Inflammatory cytokines inhibit fatty acid uptake in the liver, muscle and heart. The effect of inflammatory cytokines on placental transport is not known. It is also unknown whether male fetuses and their placentas are more sensitive than females to maternal obesity and inflammation. The overall goal of this proposal is to determine the degree to which maternal obesity alters gender-specific fatty acid transport in the placenta. Studies will be conducted in our non-human primate model of maternal obesity from which we will establish the relationship between obesity and 3rd trimester placental fatty acid transport in vivo using stable isotope-labeled fatty acid tracers. Complementary studies in women will determine the degree to which maternal BMI and fetal sex alter placental lipid uptake. The roles of inflammatory cytokines in altering fatty acid uptake kinetics will be determined in placental tissue isolated from lean women with male or female offspring. These translational studies will determine the effect of maternal obesity, fetal sex and inflammatory cytokines on placental fat transport in a human population. Upon completion of the proposed studies, we will have determined 1) the degree to which maternal obesity alters uptake and transport of LC-PUFA in the late gestation non-human primate placenta, 2) the effect of fetal gender on placental LC-PUFA uptake in women at term and 3) mechanisms by which inflammatory cytokines suppress placental fatty acid uptake in vitro. PUBLIC HEALTH RELEVANCE: The prevalence of obesity in women who give birth in the US is 1 in 5, which is associated with severe health consequences for both mother and child. Poor fetal nutrition during development due to maternal obesity is known to put the child at a higher risk of cardiovascular disease in later life. The proposed studies will help us understand how obesity during pregnancy alters the placental transfer of nutrients from mother to child and how this impacts neonatal nutrition.
描述(由申请人提供):候选人的五年职业目标是成为一个独立的研究者在产妇营养和胎盘营养运输和代谢领域。她的长期职业目标是建立一个强大的转化研究计划,利用适当的动物模型和人体研究来研究母体孕前营养对胎盘生长和功能,新生儿健康以及后代未来心血管疾病风险的影响。越来越清楚的是,胎盘在母体营养过剩或营养不足导致的不良胎儿结局的起源中起着关键作用。与此观点一致,胎盘是成人慢性疾病起源的重要因素。 候选人在分子生物学,免疫组织化学,原代细胞培养和小型和大型动物手术方面具有很强的科学背景。她获得了胎儿生理学(特别是心血管系统)的专业知识,并精通健康和心血管疾病的发育起源的文献。然而,在她实现成为母胎健康独立调查员的职业目标之前,还需要接受额外的培训。拟议的培训计划旨在提供:1)胎盘生理学和研究方法的培训,2)营养科学和研究方法的经验,3)人类调查的深入培训。俄勒冈州健康与科学大学是这种培训的理想环境。它提供了作为领先的生物医学研究和培训机构的良好声誉;心脏研究中心因其在胎儿生理学和健康与疾病的发育起源方面的工作而获得国际认可;俄勒冈州国家灵长类动物研究中心因其在怀孕方面的转化研究而获得国际认可,俄勒冈州临床和转化研究所致力于培养成功的受训者和年轻人。研究人员在转化和临床研究。 在美国,五分之一的分娩妇女肥胖(体重指数(BMI)>30 kg/m2)。这种情况与母亲和婴儿的短期和长期不良后果有关。这样的婴儿有患慢性疾病的风险,包括成人型冠心病和代谢综合征。我们的初步数据显示,超重和肥胖母亲的男性后代比女性后代具有较低水平的二十二碳己酸-必需脂肪酸的长链多不饱和(LC-PUFA)衍生物,而瘦女性的男性和女性后代之间不存在LC-PUFA水平的差异。这些缺陷导致新生儿神经和血管病变。胎儿获得的所有必需LC-PUFA都被主动转运穿过胎盘屏障。母体肥胖对胎盘向胎儿输送LC-PUFA的影响尚不清楚。由于男孩在子宫内生长迅速,因此他们对胎盘生长的投入比女孩少,并且在应对压力条件时营养不良和结果不佳的风险更大。母亲肥胖使胎盘-胎儿单位暴露于促炎分子。炎性细胞因子抑制肝脏、肌肉和心脏中的脂肪酸摄取。炎性细胞因子对胎盘转运的影响尚不清楚。也不知道男性胎儿及其胎盘是否比女性对母体肥胖和炎症更敏感。本研究的总体目标是确定母体肥胖改变胎盘中性别特异性脂肪酸转运的程度。 研究将在我们的非人灵长类动物母体肥胖模型中进行,我们将使用稳定的同位素标记的脂肪酸示踪剂在体内建立肥胖与妊娠晚期胎盘脂肪酸转运之间的关系。对女性的补充研究将确定母体BMI和胎儿性别改变胎盘脂质摄取的程度。炎症细胞因子在改变脂肪酸摄取动力学中的作用将在从具有男性或女性后代的瘦女性分离的胎盘组织中确定。这些转化研究将确定母体肥胖、胎儿性别和炎性细胞因子对人群中胎盘脂肪转运的影响。 在完成所提出的研究后,我们将确定1)母体肥胖改变妊娠晚期非人灵长类动物胎盘中LC-PUFA摄取和转运的程度,2)胎儿性别对足月妇女胎盘LC-PUFA摄取的影响,和3)炎性细胞因子体外抑制胎盘脂肪酸摄取的机制。 公共卫生关系:在美国分娩的妇女中,肥胖的患病率为五分之一,这与母亲和孩子的严重健康后果有关。众所周知,由于母亲肥胖导致的胎儿发育期间营养不良会使孩子在以后的生活中患心血管疾病的风险更高。拟议的研究将帮助我们了解怀孕期间的肥胖如何改变营养物质从母亲到孩子的胎盘转移,以及这如何影响新生儿营养。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Perrie F O'Tierney-Ginn其他文献

Perrie F O'Tierney-Ginn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Perrie F O'Tierney-Ginn', 18)}}的其他基金

Administrative Supplement to Placental miRNA profiles associated with maternal insulin resistance and fetal adiposity: maternal-placental crosstalk
与母体胰岛素抵抗和胎儿肥胖相关的胎盘 miRNA 谱的行政补充:母体-胎盘串扰
  • 批准号:
    9911807
  • 财政年份:
    2019
  • 资助金额:
    $ 8.12万
  • 项目类别:
Placental lipid metabolism impacts fetal adiposity and is programmed by the maternal metabolic milieu in early pregnancy
胎盘脂质代谢影响胎儿肥胖,并受妊娠早期母体代谢环境影响
  • 批准号:
    9397888
  • 财政年份:
    2017
  • 资助金额:
    $ 8.12万
  • 项目类别:
Maternal Metabolic Markers of infant Adiposity (MAMMA) Study supplement)
婴儿肥胖的母体代谢标志物 (MAMMA) 研究补充品)
  • 批准号:
    10591672
  • 财政年份:
    2017
  • 资助金额:
    $ 8.12万
  • 项目类别:
Placental lipid metabolism impacts fetal adiposity and is programmed by the maternal metabolic milieu in early pregnancy
胎盘脂质代谢影响胎儿肥胖,并受妊娠早期母体代谢环境影响
  • 批准号:
    10201689
  • 财政年份:
    2017
  • 资助金额:
    $ 8.12万
  • 项目类别:
Maternal obesity depresses essential fatty acid transport in the placenta
孕妇肥胖会抑制胎盘中必需脂肪酸的转运
  • 批准号:
    8643321
  • 财政年份:
    2013
  • 资助金额:
    $ 8.12万
  • 项目类别:
Maternal obesity depresses essential fatty acid transport in the placenta
孕妇肥胖会抑制胎盘中必需脂肪酸的转运
  • 批准号:
    8706701
  • 财政年份:
    2013
  • 资助金额:
    $ 8.12万
  • 项目类别:
Maternal obesity depresses essential fatty acid transport in the placenta
孕妇肥胖会抑制胎盘中必需脂肪酸的转运
  • 批准号:
    8847576
  • 财政年份:
    2013
  • 资助金额:
    $ 8.12万
  • 项目类别:
Maternal obesity depresses essential fatty acid transport in the placenta
孕妇肥胖会抑制胎盘中必需脂肪酸的转运
  • 批准号:
    8257957
  • 财政年份:
    2011
  • 资助金额:
    $ 8.12万
  • 项目类别:

相似海外基金

Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 8.12万
  • 项目类别:
    Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
  • 批准号:
    BB/W009633/1
  • 财政年份:
    2022
  • 资助金额:
    $ 8.12万
  • 项目类别:
    Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 8.12万
  • 项目类别:
    Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
  • 批准号:
    459043
  • 财政年份:
    2021
  • 资助金额:
    $ 8.12万
  • 项目类别:
    Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 8.12万
  • 项目类别:
    Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10561642
  • 财政年份:
    2019
  • 资助金额:
    $ 8.12万
  • 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 8.12万
  • 项目类别:
    Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
  • 批准号:
    2243045
  • 财政年份:
    2019
  • 资助金额:
    $ 8.12万
  • 项目类别:
    Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10359032
  • 财政年份:
    2019
  • 资助金额:
    $ 8.12万
  • 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
  • 批准号:
    428988
  • 财政年份:
    2019
  • 资助金额:
    $ 8.12万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了